514 related articles for article (PubMed ID: 3936056)
21. [Intraindividual dose-response relationship of sustained-release Elantan].
Kenedi P
Z Kardiol; 1986; 75 Suppl 3():77-9. PubMed ID: 3541420
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina.
Akhras F; Jackson G
Lancet; 1991 Oct; 338(8774):1036-9. PubMed ID: 1681355
[TBL] [Abstract][Full Text] [Related]
23. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Thadani U
Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
[TBL] [Abstract][Full Text] [Related]
24. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
[TBL] [Abstract][Full Text] [Related]
26. Isosorbide-5-mononitrate--effective monotherapy in chronic stable angina.
Akhras F; Jefferies S; Jackson G
Z Kardiol; 1985; 74 Suppl 4():16-20. PubMed ID: 3938114
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
[TBL] [Abstract][Full Text] [Related]
28. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
[TBL] [Abstract][Full Text] [Related]
30. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
[TBL] [Abstract][Full Text] [Related]
31. Isosorbide-5-mononitrate and isosorbide dinitrate retard in the treatment of coronary heart disease: a multi-centre study.
Bidoggia H
Curr Med Res Opin; 1987; 10(9):601-11. PubMed ID: 3325229
[TBL] [Abstract][Full Text] [Related]
32. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
[TBL] [Abstract][Full Text] [Related]
33. A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina.
Hall R; Chong C
Cardiology; 2001; 96(2):72-7. PubMed ID: 11740135
[TBL] [Abstract][Full Text] [Related]
34. Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
Waller DG
J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S21-7; discussion S29-31. PubMed ID: 10499557
[TBL] [Abstract][Full Text] [Related]
35. Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study.
Brun J
J Int Med Res; 1994; 22(5):266-72. PubMed ID: 7867871
[TBL] [Abstract][Full Text] [Related]
36. N-acetylcysteine modifies the acute effects of isosorbide-5-mononitrate in angina pectoris patients evaluated by exercise testing.
Svendsen JH; Klarlund K; Aldershvile J; Waldorff S
J Cardiovasc Pharmacol; 1989 Feb; 13(2):320-3. PubMed ID: 2468964
[TBL] [Abstract][Full Text] [Related]
37. [Randomized double-blind comparative study: glycerol trinitrate and isosorbide mononitrate].
Kayali A
Med Welt; 1983 Dec; 34(50):1441-4. PubMed ID: 6420639
[No Abstract] [Full Text] [Related]
38. Sustained-release isosorbide mononitrate (50 mg): optimization of a once-daily dosage form for long-term treatment of angina pectoris.
Bonn R
Am J Cardiol; 1988 Mar; 61(9):12E-14E. PubMed ID: 3348135
[TBL] [Abstract][Full Text] [Related]
39. Recent developments in the use of nitrates for treatment of angina pectoris.
Ankier SI; Warrington SJ; Sneddon JM
J Int Med Res; 1988; 16(4):249-56. PubMed ID: 3139481
[TBL] [Abstract][Full Text] [Related]
40. Antianginal efficacy and tolerability of 50 mg sustained-release isosorbide 5-mononitrate in an open twelve-month observation study.
Heepe W; Gathmann-Lewik U
Cardiology; 1987; 74 Suppl 1():34-9. PubMed ID: 3111689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
